ARCHIVES

DCT Board Okays Six Contract Recompetitions

This article is from The Cancer Letter archive.

Vol. 13 No. 41 | October 23, 1987

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

Two NCI Officials Leave for Industry, Academia: Carl Barrett Goes to Novartis, Karen Antman Named Provost and Dean at Boston University.

February 18, 2005

Toxicity Testing Reorganization Announced; Rall To Head It Up

November 17, 1978

CDC Warns Burton Patients Of Risk Of HTLV-3 Infection

August 16, 1985

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009